Long COVID and hypertension-related disorders: a report from the Japanese Society of Hypertension Project Team on COVID-19

C Matsumoto, S Shibata, T Kishi, S Morimoto… - Hypertension …, 2023 - nature.com
Abstracts The coronavirus disease 2019 (COVID-19) affects infected patients even after the
acute phase and impairs their health and quality of life by causing a wide variety of …

[HTML][HTML] Caring for older adults during the COVID-19 pandemic

V Prendki, G Tiseo, M Falcone - Clinical Microbiology and Infection, 2022 - Elsevier
Background Elderly patients represent a high-risk group with increased risk of death from
COVID-19. Despite the number of published studies, several unmet needs in care for older …

[PDF][PDF] mRNA vaccination in octogenarians 15 and 20 months after recovery from COVID-19 elicits robust immune and antibody responses that include Omicron

HK Lee, L Knabl, JI Moliva, AP Werner… - Cell Reports, 2022 - cell.com
Knowledge about the impact of prior severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) infection of the elderly on mRNA vaccination response is needed to …

SARS-CoV-2 susceptibility and COVID-19 illness course and outcome in people with pre-existing neurodegenerative disorders: Systematic review with frequentist and …

M Smadi, M Kaburis, Y Schnapper, G Reina… - The British Journal of …, 2023 - cambridge.org
Background People with neurodegenerative disease and mild cognitive impairment (MCI)
may have an elevated risk of acquiring severe acute respiratory syndrome coronavirus 2 …

Ursodeoxycholic acid does not affect the clinical outcome of SARS‐CoV‐2 infection: a retrospective study of propensity score‐matched cohorts

G Marrone, M Covino, G Merra, A Piccioni… - Liver …, 2024 - Wiley Online Library
Background Ursodeoxycholic acid (UDCA) has been recently proposed as a modulator of
angiotensin‐converting enzyme 2 (ACE2) receptor expression, with potential effects on …

Approach to COVID-19 in older adults and indications for improving the outcomes

C Tana, L Moffa, K Falasca, J Vecchiet, M Tana… - Annals of …, 2023 - Taylor & Francis
Background: COVID-19 continues to present challenges in the care of older adults with
frailty and/or comorbidities and very old patients, who can be hospitalized with severe …

[HTML][HTML] Promote COVID-19 vaccination for older adults in China

S Zang, X Zhang, Z Qu, X Chen, Z Hou - China CDC Weekly, 2022 - ncbi.nlm.nih.gov
The coronavirus disease 2019 (COVID-19) vaccine effectively reduces the possibility of
severe illness and mortality in older adults and is essential for controlling the epidemic …

Association between Clinical Frailty Scale (CFS) and clinical presentation and outcomes in older inpatients with COVID-19

A Martí-Pastor, O Moreno-Perez, E Lobato-Martínez… - BMC geriatrics, 2023 - Springer
Background Frailty is a physiological condition characterized by a decreased reserve to
stressors. In patients with COVID-19, frailty is a risk factor for in-hospital mortality. The aim of …

The management of multi-morbidity in elderly patients: Ready yet for precision medicine in intensive care?

M Beil, H Flaatten, B Guidet, S Sviri, C Jung… - Critical Care, 2021 - Springer
There is ongoing demographic ageing and increasing longevity of the population, with
previously devastating and often-fatal diseases now transformed into chronic conditions …

Clinical Frailty Scale (CFS) indicated frailty is associated with increased in-hospital and 30-day mortality in COVID-19 patients: a systematic review and meta-analysis

M Rottler, K Ocskay, Z Sipos, A Görbe, M Virág… - Annals of Intensive …, 2022 - Springer
Background The concept of frailty provides an age-independent, easy-to-use tool for risk
stratification. We aimed to summarize the evidence on the efficacy of frailty tools in risk …